Slide 3
Image is not available
A platform company
Linking pharmaceutical innovation and
commercialization with strong product
lifecycle management capability
Slide 1
Image is not available
Committed to building a pharmaceutical
ecosystem focused on delivering solutions in
an open and collaborative setting for
the benefit of all stakeholders
To fulfill unmet clinical needs
Slide 2
Image is not available
Providing competitive
products and services
To enable the more effective diagnosis
and treatment, whilst enhancing clinical
practice to the ultimate benefit of the patient
previous arrow
next arrow

Innovation

Bio-technology incubation platform

Focusing on unmet clinical needs, we collaborate with global biotech/biopharma to jointly develop first- or best-in-class innovative products. 

go

INNOVATION

Business

Commercialization platform

Adhering to the patient-centered philosophy, we are dedicated to providing competitive products and services that enable the more effective diagnosis and treatment, whilst enhancing clinical practice to the ultimate benefit of the patient.

go

BUSINESS

Cardio-cerebrovascular
and gastroenterology

Dermatology
and medical aesthetic

Ophthalmology

Southeast Asia Business

News

2023-11-27

CMS Presented its Innovative Drug ILUMETRI at the 2023 Frontier Conference on New Developments of Dermatological Treatment

On November 25, 2023, the “Innovative Medicine Brings Brighter Future of Skin Health – 2023 Frontiers Conference on New Developments of Dermatological Treatment” was grandly held in Sanya, Hainan Province. The conference was co-organized by Hainan Lecheng Real World Research Institute and Hainan Boao Lecheng International Medical Tourism Pioneer Zone Administration. It brought together many top domestic scholars and clinical experts in the dermatology field to share in-depth research on the pathogenesis, diagnosis and treatment of psoriasis and vitiligo, providing more new technologies and therapies for the clinical treatment of the related diseases.   The innovative drug for psoriasis treatment, ILUMETRI (Tildrakizumab Injection) made its debut at the conference, demonstrating CMS’s ability to empower the continuous transformation of innovative outcomes into diagnosis and therapeutic practice.     Gathering leading academic forces Exchanging new developments in dermatological treatment   More than 200 medical experts in the field of psoriasis and vitiligo […]

go
战略合作&联系我们

Partnering

We collaborate with global innovative companies in flexible structures to jointly build a pharmaceutical ecosystem in a sustainable and collaborative setting for the benefit of all stakeholders.

go

Contact Us

If you are interested in joining us, or curious about our business and products, please feel free to contact us.

go